Technical Report No. 48 Moist Heat Sterilizer Systems: Design, Commissioning, Operation, Qualification and Maintenance

Similar documents
Technical Report No. 61 Steam In Place

HISTORY AND MILESTONES

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP

COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION

The long anticipated draft of the FDA s

PDA: A Global. Association. Proposed Revisions to USP <1207> STERILE PRODUCT -

Steam Sterilizers. DLOV & DLOM series. more than sixty years of experience in sterilization. DE LAMA s Quality Management System is certified:

EQUIPMENT FOR AUTOCLAVING

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES

Technical Report No. 70 Fundamentals of Cleaning and Disinfection Programs for Aseptic Manufacturing Facilities

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective

Annex Draft Annex

Heating, ventilation, and air system encompasses heating, ventilation, and air conditioning, which is integral component of

Equipment Qualification Ensure Fit for Intended Use. IVT Amsterdam Conference Mary Sexton. 19 Mar 2015

Technical Data Monograph. STERIS VHP LTS-V - Low Temperature Surfaces Terminal Sterilization

Review Validation of aseptic processes for pharmaceuticals

PMDA Perspective: Regulatory Updates on Process Validation Standard

QUALIFICATION and VALIDATION Open Discussion Workshop QP Forum 21 st April 2016

Paradigm Change in Manufacturing Operations SM

Technical Report No. 60 Process Validation: A Lifecycle Approach

VALIDATION OF BUNG PROCESSOR

Instructions for Validation of Autoclaves

Aseptic Process Validation

á1058ñ ANALYTICAL INSTRUMENT QUALIFICATION

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

Isolator Technology TRUKING TECHNOLOGY LIMITED

Paradigm Change in Manufacturing Operations SM

Validation. An Easy to Understand Guide Validating Purified Water Systems

Revision of Chapter 7 Contract Manufacture and Analysis

STERIS FINN-AQUA Pure Steam Generator for Pharmaceutical Manufacturing

QbD Concepts Applied to Qualification and Transfer of Analytical Methods

Second Edition. New York London

Initiation of Validation

Aseptic Powder Dosing Solutions

Application of enhanced process and product knowledge to facilitate the lifecycle

Page 1

Wednesday, June 13. 7:00 a.m. 5:30 p.m. Registration Open 7:00 a.m. 8:30 a.m. Continental Breakfast

BSL3 and BSL4 Autoclaves. Laboratory Line

Automated compounding for intravenous chemotherapy

22 January Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Good Automated Manufacturing Practices (GAMP)

Process Validation of Liquid Lyophillized Formulation: A Review

35 STATION DOUBLE ROTORY COMPRESSION MACHINE

September 2, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

MASTER PLANNING FOR VALIDATION

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

PERFORMANCE QUALIFICATION PROTOCOL HVAC SYSTEM

THE WORLD LEADER IN CLEAN AIR SOLUTIONS. Pharmaceutical Clean Air Solutions PARTICULATE AND GASEOUS FILTRATION

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

Why change is inevitable in aseptic manufacturing?

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

Temperature mapping and autoclave validation specialists

GMP On Site Series. GMP Essentials

Guidelines for Process Validation of Pharmaceutical Dosage Forms

GMP MANUAL Contents. Contents (1) 1 Pharmaceutical Quality System (PQS) 2 Personnel

Q10 PHARMACEUTICAL QUALITY SYSTEM

Enabling Improvement through the Product Lifecycle: Change Management within a PQS

ICH Q8/Q8(R)

Whitepaper. High temperature HEPA filtration. Dr.-Ing. Marc Schmidt, Dr.-Ing. Lothar Gail, Hugo Hemel MSc. Preview

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

A Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody.

Proposed New USP General Chapter: The Analytical Procedure Lifecycle 1220

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

Analytical and formulation attributes

Chuck Reed at Weiler Engineering, Inc compares aseptic blow-fill-seal technology with traditional aseptic processing of pharmaceutical liquids

Connecting People, Science and Regulation

Implementation Life-cycle SOP

QbD In Drug Development. Mathew Cherian Ph.D. Director & Senior Fellow Pfizer, USA

Efficient Validation Strategies and VMPs

Guidance for Industry Process Validation: General Principles and Practices. F. Hoffman-La Roche, Ltd.

Validation of Sterilizing Grade Filters

International Journal of Chemistry and Pharmaceutical Sciences

Critical Environment Products and Services

Identification and Control of Critical Process Points Using Complementary Risk Assessments (corrected)

EU and FDA GMP Regulations: Overview and Comparison

Welcome! How do I get a CE Certificate?

Installation Qualification/Operational Qualification Protocols and Instructions

Systec Laboratory Autoclaves Systec H-Series. Horizontal floor-standing autoclaves. Systec H-Series 2D. Pass-through autoclaves.

Industry associations and regulatory bodies

Steam Sterilization Autoclaves. Series SteriMega Plus

ICH Q11 Development & manufacture of drug substances

Challenges in Implementing Knowledge Management within ICH Q10

FS 1000/3000 SIP BIOREACTORS/FERMENTORS FOR INDUSTRIAL PROCESSES

Sterilization & Chemical Resistance of Healthcare Polymers

In the Know about.appropriate Use of 3M Attest Rapid Readout Biological Indicators

Process Systems M+W Process Industries GmbH

Systematic Risk Management: An Overview of ICH Q-9

Polaris VCD. Efficient and Effective WFI Solutions WATER TECHNOLOGIES

Is it true, Annex 1 revision will have no impact on resources or cost? Walid El Azab Technical Service Manager STERIS

Biology Lab Safety. Document No Audit Title Biology Lab Safety Inspection. Conducted on 9/28/16, 1:43 PM

PHARMACEUTICAL VALIDATION AND QUALITY MANAGEMENT SYSTEM

Particulate Matter and Visual Inspection: Industry Trends 2015

Pharmaceutical Packaging

Hermetically Sealing Sliding Doors

A Journey in Global PUPSIT Implementation with Benchmarking. PDA Midwest Event Oct 5th, 2017 Jeff Gaerke P.E.

FlexAct BT (Bag Tester) Flexboy 2D November, 2015

Compounding Pharmacies and the Contract Testing Lab

Basics Of Labwasher Cleaning Validation

Transcription:

Technical Report No. 48 Moist Heat Sterilizer Systems: Design, Commissioning, Operation, Qualification and Maintenance 2010

Moist Heat Sterilizer Systems: Design, Commissioning, Operation, Qualification and Maintenance Task Force Kimberly Brown, PhD, Amethyst Technologies, LLC Linda M. Graf, Pfizer, Inc. Michael J. Guyader, Lonza Matthew E. Hofacre, Steris Corporation Richard E. Kettlewell, GlaxoSmithKline Colin Meldrum, Ciba Vision Sterile Manufacturing Ronald J. Nekula Sr., Bayer Healthcare Anton Ponomarenko, Bayer Healthcare Cody Riley, Amgen, Inc. Christopher J. Smalley, PhD, Pfizer, Inc. Victor Tsui, P.E., cgmp Associates, Inc.

Moist Heat Sterilizer Systems: Design, Commissioning, Operation, Qualification and Maintenance Technical Report No. 48 ISBN: 978-0-939459-29-2 2010 Parenteral Drug Association, Inc. All rights reserved.

Table of Contents 1.0 Introduction...4 1.1 Purpose / Scope... 4 2.0 Glossary of Terms...7 3.0 Sterilization Processes...12 3.1 Saturated Steam Processes... 12 3.1.1 Gravity Displacement Process... 13 3.1.2 Pre-Vacuum Process... 13 3.2 Air Overpressure Processes... 14 3.2.1 Steam Air Mixture Process and Superheated Water Process... 14 3.3 Decontamination Processes... 15 3.4 GMP and Non-GMP Sterilizers... 16 4.0 Comprehensive Sterilizer System Design...18 4.1 User Requirements Specifications... 19 4.1.1 Equipment Location, Installation, and Maintenance Access Considerations... 19 4.1.2 Assessing Process Requirements... 22 4.2 System Control... 23 4.3 Functional Requirements Specifications... 24 4.4 Detailed Design Specification... 25 5.0 EQUIPMENT VERIFICATION & QUALIFICATION...26 5.1 Commissioning... 26 5.1.1 Factory Acceptance Testing... 27 5.1.1.1 Leveraging the FAT... 28 5.1.1.2 Software Tests... 29 5.1.2 Site Acceptance Testing... 29 5.2 Qualification... 30 5.2.1 Static Equipment Qualification or IQ... 30 5.2.1.1 Steam Quality Testing... 30 5.2.1.1.1 Prerequisites to Physical, Chemical and Endotoxin Testing of Pure Steam... 30 5.2.1.1.2 Physical, Chemical and Endotoxin Testing... 31 5.2.2 Dynamic Equipment Qualification or OQ.. 31 5.2.2.1 Empty Chamber Temperature Distribution... 31 6.0 Cycle Development...32 6.1 Preliminary System Testing... 32 6.2 Thermal Measurement Test Equipment... 32 6.3 Sterilization Cycle Optimization... 33 6.3.2 Pressure Vacuum (Pre-vacuum) Cycle Development... 42 7.0 On-Going Control...43 7.1 Sterilizer System Maintenance... 43 7.2 Calibration... 44 7.2.1 Calibration Records... 45 8.0 Documentation...46 9.0 Appendix...47 Appendix A: Design Considerations... 47 Appendix B: Sterilizer Verification Activities... 58 Appendix C: Documentation... 62 10.0 References...63

Figures and Tables Index Figure 1.1-1 Table 3.3-1 Figure 3.3-1 Table 3.4-1 Table 4.0-1 Figure 4.1.1-1 Figure 4.1.1-2 Figure 4.1.1-3 Figure 5.1.1-1 Figure 6.3-1 Figure 6.3-2 validation Life-Cycle Activities... 6 BioSafety Levels and Sterilizer Requirements... 15 Decontamination and Standard Steam Flow Cycle Comparison... 16 GMP and Non-GMP Comparison Chart... 17 Design Qualification Example... 18 Facility Design Example One... 20 Example of Dual Wall Seals... 21 Example of Wall Seal Facility Design... 21 Sterilizer Manufacture and Testing... 28 example of Heating Uniformity Problem During Initial Development Study... 34 example of Heating Uniformity Progression During Cycle Development Study... 34 Figure 6.3-3 example of Heating Uniformity Progression During Cycle Development Study... 35 Table 6.3-1 Cycle Optimization Considerations Table... 36 Figure A-1 example of Sterilizer Chamber... 47 Figure A-2 example of Sliding Door... 49 Figure A-3 example of Swing Door... 49 Figure A-4 example of Active Door Gasket... 50 Figure A-5 example of Inlet Air Filter... 52 Figure A-6 example of Typical Liquid Ring Vacuum Pump... 52 Figure A-7 example of Sterilizer Control Panel with HMI... 53 Figure A-8 example of Electric Steam Generator... 55 Figure A-9 example of Air Differential Seal... 57 Figure A-10 example of Biological Safety Seal... 57 Figure C-1 Documentation... 62

1.0 Introduction Moist Heat Sterilization is a process that uses moist heat as the lethal agent to render liquid and porous/hard goods items free of viable microorganisms. There are two main types of processes used in moist heat sterilization: saturated steam sterilization and air overpressure sterilization. Saturated steam sterilization is used primarily for porous, hard goods loads, while air overpressure is used for liquid loads. Sterilizers are used to sterilize many types of articles, including: Porous/hard goods, e.g., equipment, tools, laboratory glassware, product components, packaging, or devices Product components that are not part of a porous or liquid load, e.g., vials and syringes Cleaning materials and product intermediates Product in final containers (terminal sterilization) Heat labile media Biological solutions and products, equipment, tools Air over-pressure applications are used to minimize destruction or distortion of plastic containers or syringes containing liquids. The primary objective of the task force was to develop a science-based technical report on moist heat sterilizers that may be used in all regulatory environments and can be used by organizations to develop their own program for equipment qualification. To this end, prescription has been avoided, and region-specific regulatory expectations are not always addressed. This report should be considered a guide and is not intended to establish standards for sterilization systems. It is intended to be a singlesource overview that complements existing documents listed in the reference section. References to appropriate and up-to-date scientific publications, international regulatory documents, journal articles, technical papers and books are used where more detail and supportive data can be found. The task force was composed of European and North American industry professionals to ensure the methods, terminology and practices of sterilization science presented reflect sound science and can be used globally. This technical report was disseminated in draft for public review and comment. 1.1 Purpose / Scope This Technical Report addresses moist heat sterilizers intended for use in the pharmaceutical, medical device and biotechnology industries. This technical report focuses on the design and operation of moist heat sterilizers, from the development of User Requirements Specifications (URS) through equipment qualification (Installation Qualification (IQ)/Operational Qualification (OQ)) and culminating with ongoing maintenance requirements. The focus of this report does not include Performance Qualification (PQ). The reader is directed to PDA Technical Report No. 1: Validation of Moist Heat Sterilization Processes Cycle Design, Development, Qualification and Ongoing Control for discussion of load cycle development and process Performance Qualification. (1) This technical report addresses: Setting User Requirements and Specifications Design Qualification (DQ) Equipment and Control System Design Functional Requirements for the moist heat sterilizer and expectations for utilities supporting the sterilizer 4 2010 Parenteral Drug Association, Inc. Technical Report No. 48

Equipment Operation, including calibration and maintenance Equipment Qualification, which may include Factory Acceptance Testing (FAT), Site Acceptance Testing (SAT), and commissioning On-going control requirements Cycle Development This Technical Report will not address, and considers outside the scope of its content, steam-inplace, which will be covered in a subsequent PDA technical report. Several aspects described within this document may be useful for consideration when developing these types of systems; however the content of the Technical Report has been prepared specifically for moist heat sterilizers. A lifecycle approach is recommended for the specification, design, testing and qualification of moist heat sterilizer systems, and the reader should consult Technical Report No. 1 in this regard. (1) The sterilizer life cycle approach to validation activities (see Figure 1.1-1) should include a Change Control Program and a Quality Risk Management (QRM) Program. A Change Control Program would encompass the requirements for documenting and verifying all changes made to the sterilizer that would affect its validated state. The QRM program would provide the end-user with the tools required to make intelligent risk-based decisions with respect to the design of the sterilizer, the sterilization process itself, and the operation of the sterilizer. QRM may be used during qualification and validation to prioritize and develop test requirements and acceptance criteria, and may also be used in conjunction with Change Control to determine the appropriate requalification interval for the sterilizer. PDA Technical Report No. 44: Quality Risk Management for Aseptic Processes outlines an approach that can be adopted. (2) Points to consider for equipment qualification activities are provided in this report. However, when to conduct these activities and the personnel who will perform them is determined by the user. Activity overlap or gaps should be avoided where possible. Personnel performing these activities should have the suitable skills and qualifications commensurate to their assigned responsibilities. Technical Report No. 48 2010 Parenteral Drug Association, Inc. 5